Concepedia

Helmi Zaghdane

HZ

4

Publications

171

Citations

4

H-Index

2010

Active since

Affiliations

Merck Canada Inc. (Canada)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Helmi Zaghdane is an author at Merck Canada Inc. (Canada) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2010–2015

4

Publications

4

Identification and Characterization of a Selective Allosteric Antagonist of Human P2X4 Receptor Channels

Ariel R. Ase, Nicolette S. Honson, Helmi Zaghdane et al. · Molecular Pharmacology · 2015 · 78 citations

Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases

Michel Gallant, Christian Beaulieu, Carl Berthelette et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 49 citations · Full text

, , +5

Novel Quinoline-Based P2–P4 Macrocyclic Derivatives As Pan-Genotypic HCV NS3/4a Protease Inhibitors

Unmesh Shah, Charles Jayne, Samuel Chackalamannil et al. · ACS Medicinal Chemistry Letters · 2014 · 25 citations · Full text

, , +15

New indole amide derivatives as potent CRTH2 receptor antagonists

Helmi Zaghdane, Michael J. Boyd, John Colucci et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 19 citations · Full text

, , +3

Rows per page

1–4 of 4